-
December 16, 2021 Australia Rejects Bid to Reschedule Psilocybin, MDMA for Therapeutic UseMind Medicine Australia, a psychedelics advocacy organization that filed the application, says the country "lost...
-
December 3, 2021 Psychedelic Business Spotlight: December 3This week in psychedelic business news: MAPS pioneers new funding structure; FDA green lights a...
-
December 2, 2021 DEA Boosts Psychedelics Production (Again) to Meet Research DemandDrug Enforcement Agency also addresses concerns from Native American Church regarding peyote poaching for mescaline...
-
November 29, 2021 Combining Psychedelics: Is It Safe?Mixing psychedelics goes by many names in pop culture: hippie flipping (MDMA and mushrooms) and...
-
November 23, 2021 Manhattan Hospital Partners with Cybin to Provide Psychedelic Therapies to Marginalized Communities“It’s time for psychedelic medicine to climb down from the ivory tower and into the...
-
November 16, 2021 Australian Doctor Sues State Over Patient Access to MDMA“People will continue to kill themselves, and my patient will continue to suffer in silence...
-
November 15, 2021 DEA Quadruples Psilocybin Manufacturing for Research in Final 2021 Production QuotasDrug Enforcement Agency also hugely boosts MDMA and DMT quotas “in response to the nationwide...
-
November 10, 2021 MAPS Expands MDMA-Assisted Therapy for PTSD Trial Into CanadaRick Doblin's organization partners with Numinus Wellness to manage the Canadian sites where therapists will...
-
November 8, 2021 Veteran Who Cured PTSD with MDMA-Assisted Therapy Wows NBC ‘Today’ Show Anchors"This treatment is the reason that my son has a father instead of a folded...
-
November 4, 2021 Why We’re Excited About Compass Pathways’ New Clinical Trial Treating PTSD with PsilocybinCompass Pathways (Nasdaq: CMPS) has announced the launch of a brand new psychedelic clinical trial,...
